BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/21/2025 7:06:13 AM | Browse: 2 | Download: 21
 |
Received |
|
2025-07-16 02:43 |
|
Peer-Review Started |
|
2025-07-16 02:48 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-08-04 07:44 |
|
Revised |
|
2025-08-23 18:34 |
|
Second Decision |
|
2025-10-27 02:41 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-10-27 08:04 |
|
Articles in Press |
|
2025-10-27 08:04 |
|
Publication Fee Transferred |
|
2025-08-30 15:13 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-11-14 09:02 |
|
Publish the Manuscript Online |
|
2025-11-21 07:06 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Perioperative immunotherapy combined with standard therapy for human epidermal growth factor receptor 2-positive locally advanced gastric cancer: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xiao-Ting Ma, Guang-Yu Yao, Jian-Li Li, Xi-Cheng Wang and Yi Ba |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| CAMS Innovation Fund for Medical Sciences (CIFMS) |
2023-I2M-3-012 |
|
| Corresponding Author |
Yi Ba, Department of Cancer Medical Center, Peking Union Medical College Hospital, Correspondence to: Yi Ba, E-mail: <email>bayi@pumch.cn</email>, Beijing 100730, China. bayi@pumch.cn |
| Key Words |
Human epidermal growth factor receptor 2; Immune checkpoint inhibitor; Gastric cancer; Neoadjuvant therapy; Trastuzumab; Case report |
| Core Tip |
The efficacy and safety of immune checkpoint inhibitors (ICIs) combination therapy in the perioperative period of human epidermal growth factor receptor 2 (HER2)-positive gastric cancer (GC) have not been confirmed by large-scale clinical studies. This study introduces a case of neoadjuvant treatment for HER2-positive GC using standard chemotherapy combined with anti-HER2 therapy, and systematically summarizes the current related research on chemotherapy combined with targeted therapy and ICI-based combined therapy. The efficacy of ICI combined therapy during the perioperative period still requires further confirmation through a phase III clinical trial. |
| Publish Date |
2025-11-21 07:06 |
| Citation |
<p>Ma XT, Yao GY, Li JL, Wang XC, Ba Y. Perioperative immunotherapy combined with standard therapy for human epidermal growth factor receptor 2-positive locally advanced gastric cancer: A case report. <i>World J Clin Oncol</i> 2025; 16(11): 112029</p> |
| URL |
https://www.wjgnet.com/2218-4333/full/v16/i11/112029.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v16.i11.112029 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
